K. Hudson, N. Cross, N. Jordan-Mahy, R. Leyland, The Extrinsic and Intrinsic Roles of PD-L1 and Its Receptor PD-1: Implications for Immunotherapy Treatment. Front. Immunol. 11, 568931 (2020)
Article PubMed PubMed Central Google Scholar
Y. Han, D. Liu, L. Li, PD-1/PD-L1 pathway: current researches in cancer. Am. J. Cancer Res. 10, 727–742 (2020)
PubMed PubMed Central Google Scholar
H. Yamaguchi, J.M. Hsu, W.H. Yang, M.C. Hung, Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics. Nat. Rev. Clin. Oncol. 19, 287–305 (2022)
J. Liu, Z. Chen, Y. Li, W. Zhao, J. Wu, Z. Zhang, PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy. Front. Pharmacol. 12, 731798 (2021)
Article PubMed PubMed Central Google Scholar
S. Upadhaya, S.T. Neftelinov, J. Hodge, J. Campbell, Challenges and opportunities in the PD1/PDL1 inhibitor clinical trial landscape. Nat. Rev. Drug. Discov. 21, 482–483 (2022)
X.W. Qiao, J. Jiang, X. Pang, M.C. Huang, Y.J. Tang, X.H. Liang, Y.L. Tang, The Evolving Landscape of PD-1/PD-L1 Pathway in Head and Neck Cancer. Front. Immunol. 11, 1721 (2020)
Article PubMed PubMed Central Google Scholar
P. Dong, Y. Xiong, J. Yue, S.J.B. Hanley, H. Watari, Tumor-Intrinsic PD-L1 Signaling in Cancer Initiation, Development and Treatment: Beyond Immune Evasion. Front. Oncol. 8, 386 (2018)
Article PubMed PubMed Central Google Scholar
J.H. Cha, L.C. Chan, C.W. Li, J.L. Hsu, M.C. Hung, Mechanisms Controlling PD-L1 Expression in Cancer. Mol. Cell. 76, 359–370 (2019)
Article PubMed PubMed Central Google Scholar
P. Yadollahi, Y.K. Jeon, W.L. Ng, I. Choi, Current understanding of cancer-intrinsic PD-L1: regulation of expression and its protumoral activity. BMB Rep. 54, 12–20 (2021)
Article PubMed PubMed Central Google Scholar
C.A. Clark, H.B. Gupta, G. Sareddy, S. Pandeswara, S. Lao, B. Yuan, J.M. Drerup, A. Padron, J. Conejo-Garcia, K. Murthy, Y. Liu, M.J. Turk, K. Thedieck, V. Hurez, R. Li, R. Vadlamudi, T.J. Curiel, Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma. Cancer Res. 76, 6964–6974 (2016)
Article PubMed PubMed Central Google Scholar
F. Zheng, J. Dang, H. Zha, B. Zhang, M. Lin, F. Cheng, PD-L1 Promotes Self-Renewal and Tumorigenicity of Malignant Melanoma Initiating Cells. Biomed. Res. Int. 2017, 1293201 (2017)
Article PubMed PubMed Central Google Scholar
T. Kong, R. Ahn, K. Yang, X. Zhu, Z. Fu, G. Morin, R. Bramley, N.C. Cliffe, Y. Xue, H. Kuasne, Q. Li, S. Jung, A.V. Gonzalez, S. Camilleri-Broet, M.C. Guiot, M. Park, J. Ursini-Siegel, S. Huang, CD44 Promotes PD-L1 Expression and Its Tumor-Intrinsic Function in Breast and Lung Cancers. Cancer Res. 80, 444–457 (2020)
C. Chen, S. Li, J. Xue, M. Qi, X. Liu, Y. Huang, J. Hu, H. Dong, K. Ling, PD-L1 tumor-intrinsic signaling and its therapeutic implication in triple-negative breast cancer. JCI Insight. 6, e131458 (2021)
P. Cui, P. Jing, X. Liu, W. Xu, Prognostic Significance of PD-L1 Expression and Its Tumor-Intrinsic Functions in Hypopharyngeal Squamous Cell Carcinoma. Cancer Manag. Res. 12, 5893–5902 (2020)
Article PubMed PubMed Central Google Scholar
D.H. Geum, D.S. Hwang, C.H. Lee, S.D. Cho, M.A. Jang, M.H. Ryu, U.K. Kim, PD-L1 expression correlated with clinicopathological factors and Akt/Stat3 pathway in oral SCC. Life (Basel). 12, 238 (2022)
M.M. Kim, N. Rajapakse, S.K. Kim, Anti-inflammatory effect of Ishige okamurae ethanolic extract via inhibition of NF-kappaB transcription factor in RAW 264.7 cells. Phytother. Res. 23, 628–634 (2009)
H.-W. Yang, M. Son, J. Choi, S. Oh, Y.-J. Jeon, K. Byun, B.M. Ryu, Ishige okamurae reduces blood glucose levels in high-fat diet mice and improves glucose metabolism in the skeletal muscle and pancreas. Fish. Aquat. Sci. 23, 24 (2020)
K.H.N. Fernando, H.W. Yang, Y. Jiang, Y.J. Jeon, B. Ryu, Ishige okamurae extract and its constituent Ishophloroglucin A attenuated in vitro and in vivo high glucose-induced angiogenesis. Int. J. Mol. Sci. 20, 5542 (2019)
M.J. Bae, F. Karadeniz, B.N. Ahn, C.S. Kong, Evaluation of Effective MMP Inhibitors from Eight Different Brown Algae in Human Fibrosarcoma HT1080 Cells. Prev. Nutr. Food Sci. 20, 153–161 (2015)
Article PubMed PubMed Central Google Scholar
H.W. Yang, K.H.N. Fernando, J.Y. Oh, X. Li, Y.J. Jeon, B. Ryu, Anti-obesity and anti-diabetic effects of Ishige okamurae. Mar. Drugs. 17, 202 (2019)
X. Li, H.W. Yang, Y. Jiang, J.Y. Oh, Y.J. Jeon and B. Ryu, Ishophloroglucin A isolated from Ishige okamurae suppresses melanogenesis induced by alpha-MSH: in vitro and in vivo. Mar. Drugs. 18, 470 (2020)
H.W. Yang, M. Son, J. Choi, S. Oh, Y.J. Jeon, K. Byun, B. Ryu, Effect of Ishophloroglucin A, a component of Ishige okamurae, on glucose homeostasis in the pancreas and muscle of high fat diet-fed mice. Mar. Drugs. 17, 608 (2019)
K.N. Kim, S.J. Heo, S.M. Kang, G. Ahn, Y.J. Jeon, Fucoxanthin induces apoptosis in human leukemia HL-60 cells through a ROS-mediated Bcl-xL pathway. Toxicol. In Vitro. 24, 1648–1654 (2010)
K.N. Kim, G. Ahn, S.J. Heo, S.M. Kang, M.C. Kang, H.M. Yang, D. Kim, S.W. Roh, S.K. Kim, B.T. Jeon, P.J. Park, W.K. Jung, Y.J. Jeon, Inhibition of tumor growth in vitro and in vivo by fucoxanthin against melanoma B16F10 cells. Environ. Toxicol. Pharmacol. 35, 39–46 (2013)
S.-M. Kang, A.-D. Kim, S.-J. Heo, K.-N. Kim, S.-H. Lee, S.-C. Ko, Y.-J. Jeon, Induction of apoptosis by diphlorethohydroxycarmalol isolated from brown alga, Ishige okamurae. J. Funct. Foods. 4, 433–439 (2012)
Y. Sun, L. Ma, The emerging molecular machinery and therapeutic targets of metastasis. Trends Pharmacol. Sci. 36, 349–359 (2015)
Article PubMed PubMed Central Google Scholar
S. Wiegand, A. Zimmermann, T. Wilhelm, J.A. Werner, Survival After Distant Metastasis in Head and Neck Cancer. Anticancer Res. 35, 5499–5502 (2015)
F. Ionna, P. Bossi, A. Guida, A. Alberti, P. Muto, G. Salzano, A. Ottaiano, F. Maglitto, D. Leopardo, M. De Felice, F. Longo, S. Tafuto, G. Della Vittoria Scarpati, F. Perri, Recurrent/metastatic squamous cell carcinoma of the head and neck: a big and intriguing challenge which may be resolved by integrated treatments combining locoregional and systemic therapies. Cancers (Basel). 13, 2371 (2021)
D. Ribatti, R. Tamma, T. Annese, Epithelial-Mesenchymal Transition in Cancer: A Historical Overview. Transl. Oncol. 13, 100773 (2020)
Article PubMed PubMed Central Google Scholar
R. Xu, J.Y. Won, C.H. Kim, D.E. Kim, H. Yim, Roles of the Phosphorylation of Transcriptional Factors in Epithelial-Mesenchymal Transition. J. Oncol. 2019, 5810465 (2019)
Article PubMed PubMed Central Google Scholar
A. Dongre, R.A. Weinberg, New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat. Rev. Mol. Cell Biol. 20, 69–84 (2019)
L. Chen, Y. Xiong, J. Li, X. Zheng, Q. Zhou, A. Turner, C. Wu, B. Lu, J. Jiang, PD-L1 Expression Promotes Epithelial to Mesenchymal Transition in Human Esophageal Cancer. Cell Physiol. Biochem. 42, 2267–2280 (2017)
Y.W. Koh, J.H. Han, S. Haam, Expression of PD-L1, cancer stem cell and epithelial-mesenchymal transition phenotype in non-small cell lung cancer. Pathology 53, 239–246 (2021)
A. Cano, M.A. Neto, in Encyclopedia of Cancer. ed. by M. Schwab (Springer, Berlin, 2011), pp.3456–3459
L.A. Osorio, N.M. Farfan, E.A. Castellon, H.R. Contreras, SNAIL transcription factor increases the motility and invasive capacity of prostate cancer cells. Mol. Med. Rep. 13, 778–786 (2016)
B.N. Smith, L.J. Burton, V. Henderson, D.D. Randle, D.J. Morton, B.A. Smith, L. Taliaferro-Smith, P. Nagappan, C. Yates, M. Zayzafoon, L.W. Chung, V.A. Odero-Marah, Snail promotes epithelial mesenchymal transition in breast cancer cells in part via activation of nuclear ERK2. PLoS ONE 9, e104987 (2014)
Article PubMed PubMed Central Google Scholar
R. Nishioka, S. Itoh, T. Gui, Z. Gai, K. Oikawa, M. Kawai, M. Tani, H. Yamaue, Y. Muragaki, SNAIL induces epithelial-to-mesenchymal transition in a human pancreatic cancer cell line (BxPC3) and promotes distant metastasis and invasiveness in vivo. Exp. Mol. Pathol. 89, 149–157 (2010)
Y. Wang, J. Shi, K. Chai, X. Ying, B.P. Zhou, The Role of Snail in EMT and Tumorigenesis. Curr. Cancer Drug Targets. 13, 963–972 (2013)
Article PubMed PubMed Central Google Scholar
E. Kang, J. Seo, H. Yoon and S. Cho, The Post-Translational Regulation of Epithelial-Mesenchymal Transition-Inducing Transcription Factors in Cancer Metastasis. Int J Mol Sci. 22, 3591 (2021)
T. Domoto, I.V. Pyko, T. Furuta, K. Miyashita, M. Uehara, T. Shimasaki, M. Nakada, T. Minamoto, Glycogen synthase kinase-3beta is a pivotal mediator of cancer invasion and resistance to therapy. Cancer Sci. 107, 1363–1372 (2016)
Article PubMed PubMed Central Google Scholar
J.A. McCubrey, L.S. Steelman, F.E. Bertrand, N.M. Davis, M. Sokolosky, S.L. Abrams, G. Montalto, A.B. D’Assoro, M. Libra, F. Nicoletti, R. Maestro, J. Basecke, D. Rakus, A. Gizak, Z.N. Demidenko, L. Cocco, A.M. Martelli, M. Cervello, GSK-3 as potential target for therapeutic intervention in cancer. Oncotarget 5, 2881–2911 (2014)
Article PubMed PubMed Central Google Scholar
D. Nagarajan, T. Melo, Z. Deng, C. Almeida, W. Zhao, ERK/GSK3beta/Snail signaling mediates radiation-induced alveolar epithelial-to-mesenchymal transition. Free Radic Biol Med. 52, 983–992 (2012)
Y. Liu, H. Zhou, R. Zhu, F. Ding, Y. Li, X. Cao, Z. Liu, SPSB3 targets SNAIL for degradation in GSK-3beta phosphorylation-dependent manner and regulates metastasis. Oncogene 37, 768–776 (2018)
Y. Xu, S.H. Lee, H.S. Kim, N.H. Kim, S. Piao, S.H. Park, Y.S. Jung, J.I. Yook, B.J. Park, N.C. Ha, Role of CK1 in GSK3beta-mediated phosphorylation and degradation of snail. Oncogene 29, 3124–3133 (2010)
R. He, S. Du, T. Lei, X. Xie, Y. Wang, Glycogen synthase kinase 3beta in tumorigenesis and oncotherapy (Review). Oncol. Rep. 44, 2373–2385 (2020)
留言 (0)